Literature DB >> 2957843

Lymphocyte subsets in urologic cancer patients.

M Shaw, P Ray, M Rubenstein, P Guinan.   

Abstract

Peripheral blood T lymphocyte subsets were quantitated by monoclonal antibodies in 91 patients with urologic malignancies as well as eight age-matched controls. In general, the presence of cancer and increasing stage were associated with a relative decrease in helper and an increase in suppressor T-cell activity as well as a decreased T4/T8 cell ratio. Therapy in the form of androgen depletion reversed these trends and restored helper and suppressor levels as well as the T4/T8 ratio to control values. In a small subset of sixteen patients surgery had only modest immediate (prostate) and long term (kidney) effects on these parameters.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957843     DOI: 10.1007/bf00254434

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  25 in total

1.  A plasma factor inhibiting lymphocyte reactivity in urologic cancer patients.

Authors:  A P McLaughlin; J D Brooks
Journal:  J Urol       Date:  1974-09       Impact factor: 7.450

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Editorial retrospective. Human lymphocyte subpopulations in metastatic neoplasia--six years later.

Authors:  D S Robbins; H H Fudenberg
Journal:  N Engl J Med       Date:  1983-06-30       Impact factor: 91.245

4.  Lymphocyte subsets in renal carcinoma--a sequential study using monoclonal antibodies.

Authors:  A W Ritchie; K James; H S Micklem; G D Chisholm
Journal:  Br J Urol       Date:  1984-04

5.  Strategies for generating monoclonal antibodies defining human t-lymphocyte differentiation antigens.

Authors:  P C Kung; M A Talle; M E DeMaria; M S Butler; J Lifter; G Goldstein
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

6.  Natural killer cell activity and response to phytohaemagglutinin compared with the histological diagnosis of patients with transitional cell carcinoma of the bladder.

Authors:  V Britten; R C Rees; A Clegg; G T Smith; C W Potter; M Fox; J L Williams
Journal:  Br J Urol       Date:  1982-06

7.  In vitro cytotoxicity of lymphocyte subpopulations against autologous human bladder tumor cells.

Authors:  F Jacobsen
Journal:  Acta Pathol Microbiol Scand C       Date:  1981-08

8.  Increase of T lymphocytes bearing immunoglobulin G receptors during circulation in human renal cell carcinoma.

Authors:  H Akaza; K Kobayashi; T Umeda; T Niijima
Journal:  J Urol       Date:  1982-09       Impact factor: 7.450

9.  Functional properties of natural killer cells in carcinoma of the prostate.

Authors:  M Wirth; B J Schmitz-Dräger; R Ackermann
Journal:  J Urol       Date:  1985-06       Impact factor: 7.450

10.  Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.

Authors:  T Kalland; S Haukaas
Journal:  Invest Urol       Date:  1981-05
View more
  1 in total

1.  Characterization of peripheral blood T-cell subpopulation of bladder cancer patients.

Authors:  A Greenstein; M Pecht; I Kaver; N Trainin; Z Braf
Journal:  Urol Res       Date:  1991
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.